Document:

EXHIBIT 10.1

                             NOTE PURCHASE AGREEMENT

      THIS NOTE PURCHASE AGREEMENT (the "Agreement") is made as of the 22nd day
of April, 2005, by and between theglobe.com, inc., a Delaware corporation (the
"Company"), and the each purchaser now or hereinafter (in accordance with
Section 2 below) listed on Schedule A hereto (individually, an "Investor" and
collectively, the "Investors").

      WHEREAS, the initial Investors set forth on Schedule A are willing to lend
the Company the aggregate sum of One Million Five Hundred Thousand Dollars
($1,500,000) pursuant to the terms of this Agreement and a promissory note (a
"Note") convertible into shares of the Company's common stock, $.001 par value
(the "Common Stock"), all as more particularly described in the form of Note
attached hereto as Exhibit A; and

      WHEREAS, as more particularly set forth on Schedule A hereof, the Company
has also granted certain parties, for a period of ninety (90) days from the date
hereof, the optional right to purchase (each an "Option") additional Notes
pursuant to this Agreement such that the aggregate amount of Notes issued
hereunder may reach the aggregate sum of Four Million Dollars ($4,000,000) (the
"Offering Limit");

      WHEREAS, the parties have agreed that the obligation to repay the Notes
shall be secured by a pledge of substantially all of the assets of the Company
and its subsidiaries pursuant to the terms of a Security Agreement in the form
attached hereto as Exhibit B; and

      WHEREAS, as a material inducement to the Investors to purchase the Notes
and in recognition of the substantial benefit which the Company's subsidiaries
will receive from the proceeds of the Notes, the subsidiaries have agreed to
guaranty the Notes pursuant to the terms of a Guaranty in the form attached
hereto as Exhibit C;

      NOW, THEREFORE, for good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, and in consideration of the
premises and the mutual agreements, representations and warranties, provisions
and covenants contained herein, the parties hereto, intending to be legally
bound hereby, agree as follows:

      1. Purchase and Sale of Notes; Option. On the applicable Closing Date (as
hereinafter defined), subject to the terms and conditions of this Agreement,
each Investor hereby agrees to purchase and the Company hereby agrees to sell
and issue a Note in the principal amount set forth opposite such Investor's name
on Schedule A hereto. In addition, the Company does hereby grant an Option to
the Investors (or such other parties who are identified on Schedule A and whom
shall upon any exercise of the Option, shall thereafter be deemed "Investors"
for all purposes of this Agreement) to acquire in accordance with Section 2
hereof that additional principal amount of the Notes as is set forth opposite
such Investors (or other parties') name, all as more particularly described on
Schedule A.

                                       1
<PAGE>

      2. The Closing(s). Subject to the conditions set forth below, the initial
purchase and sale of the Notes shall take place at the offices of Proskauer Rose
LLP, 2255 Glades Road, Boca Raton, Florida, 33414, on or before April 22, 2005,
or at such other time and place as the Company and the Investors mutually agree
(the "Closing" and the "Closing Date"). Additional closings may be held with
respect to additional purchases and sales of the Notes up to the Offering Limit
upon exercise of any Option, which closings shall be held as soon as practicable
after any exercise of an Option (each a "Closing"). Any party holding an Option
shall exercise such Option, if at all, by delivering to the Company on or before
the 90th day from the date hereof a notice of exercise setting forth the amount
of Notes to be acquired. The Investors for any such additional Closings shall
execute and deliver a joinder to this Agreement in a form satisfactory to the
Company. At the Closing, the Company shall deliver to each Investor: (i) an
executed counterpart of this Agreement, the Security Agreement and Guaranty; and
(ii) such Investor's original Note in the amount set forth opposite such
Investor's name on Schedule A. At the Closing each Investor shall fund his or
her respective Note by cashier's check or wire transfer of immediately available
funds (to an account designated by the Company).

      3. Closing Conditions. The obligation of each Investor to purchase and
fund its Note at the applicable Closing is subject to the fulfillment, to the
Investor's reasonable satisfaction, prior to or at the Closing in question, of
each of the following conditions:

            3.1 Representations and Warranties. The representations and
warranties of the Company contained in this Agreement shall be true and correct
in all material respects on the date hereof and on and as of the applicable
Closing Date as if made on and as of such date.

            3.2 Notes. At the Closing, the Company shall have tendered to the
Investor the appropriate Note.

            3.3 No Actions. No action, proceeding, investigation, regulation or
legislation shall have been instituted, threatened or proposed before any court,
governmental agency or authority or legislative body to enjoin, restrain,
prohibit, or obtain substantial damages in respect of, this Agreement or the
consummation of the transactions contemplated by this Agreement.

            3.4 Proceedings and Documents. All proceedings in connection with
the transactions contemplated hereby and all documents and instruments incident
to such transactions shall be satisfactory in substance and form to the
Investor, and the Company shall have received all such counterpart originals or
certified or other copies of such documents as the Investors may reasonably
request.

      4. Representations and Warranties of the Company. The Company hereby
represents and warrants to Investor that:

            4.1 Organization, Good Standing and Qualification. The Company is a
corporation duly organized, validly existing and in good standing under the laws
of the State of Delaware. The Company is duly qualified to transact business and
is in good standing in each jurisdiction in which the failure to so qualify
would have a material adverse effect on its business or properties.

                                       2
<PAGE>

            4.2 Capitalization and Voting Rights. The authorized capital of the
Company as of April 11, 2005 consists of:

                  (a) Preferred Stock. 3,000,000 shares of Preferred Stock, par
value $0.001 per share (the "Preferred Stock"), of which there are no shares
presently issued and outstanding.

                  (b) Common Stock. 500,000,000 shares of common stock, par
value $0.001 per share ("Common Stock"), of which 175,798,747 shares were issued
and outstanding.

            4.3 Authorization. All corporate action on the part of the Company,
its officers, directors and stockholders necessary for the authorization,
execution and delivery of this Agreement and the Security Agreement and the
performance of all obligations of the Company hereunder and thereunder, and the
authorization (or reservation for issuance), sale and issuance of the Notes and
the Common Stock into which the Notes are convertible or exercisable (the
"Underlying Securities"), have been taken on or prior to the date hereof.

            4.4 Valid Issuance of the Underlying Securities. The Underlying
Securities when issued and delivered in accordance with the terms of this
Agreement and the Notes for the consideration expressed herein and therein, will
be duly and validly issued, fully paid and nonassessable and will be free of
restrictions on transfer, other than restrictions on transfer under this
Agreement and under applicable state and federal securities laws.

            4.5 Offering. Subject to the truth and accuracy of each Investor's
representations set forth in Section 5 of this Agreement, the offer and issuance
of the Notes, together with the Underlying Securities, as contemplated by this
Agreement are exempt from the registration requirements of the Securities Act of
1933, as amended (the "1933 Act") and the qualification or registration
requirements of state securities laws or other applicable blue sky laws. Neither
the Company nor any authorized agent acting on its behalf will take any action
hereafter that would cause the loss of such exemptions.

            4.6 Public Reports. The Company is current in its filing obligations
under the Securities Act of 1934, as amended (the "1934 Act"), including without
limitation as to its filings of Annual Reports on Form 10-K (or 10-KSB, as
applicable) and Quarterly Reports on Form 10-Q (or 10-QSB, as
applicable)(collectively, the "Public Reports"). The Public Reports do not
contain any untrue statement of a material fact or omit to state any fact
necessary to make any statement therein not misleading. The financial statements
included within the Public Reports for the fiscal year ended December 31, 2003,
and for the fiscal year ended December 31, 2004 (the "Financial Statements"),
have been prepared in accordance with generally accepted accounting principles
("GAAP") applied on a consistent basis throughout the periods indicated. The
Financial Statements fairly present, in all material respects, the financial
condition and operating results of the Company as of the dates, and for the
periods, indicated therein.

                                       3
<PAGE>

            4.7 Compliance With Laws. Neither the Company nor any subsidiary has
violated any law or any governmental regulation or requirement which violation
has had or would reasonably be expected to have a material adverse effect on its
business or prospects, and neither the Company nor any subsidiary has received
written notice of any such violation.

            4.8 Violations. The consummation of the transactions contemplated by
this Agreement and all other documents and instruments required to be delivered
in connection herewith and therewith, including without limitation, the Security
Agreement and Notes, will not result in or constitute any of the following: (a)
a violation of any provision of the certificate of incorporation, bylaws or
other governing documents of the Company; (b) a violation of any provisions of
any applicable law or of any writ or decree of any court or governmental
instrumentality; (c) a default or an event that, with notice or lapse of time or
both, would be a default, breach, or violation of a lease, license, promissory
note, conditional sales contract, commitment, indenture, mortgage, deed of
trust, or other agreement, instrument, or arrangement to which the Company is a
party or by which the Company or its property is bound; (d) an event that would
permit any party to terminate any agreement or to accelerate the maturity of any
indebtedness or other obligation of the Company; or (e) the creation or
imposition of any lien, pledge, option, security agreement, equity, claim,
charge, encumbrance or other restriction or limitation on the capital stock or
on any of the properties or assets of the Company.

            4.9 Consents; Waivers. No consent, waiver, approval or authority of
any nature, or other formal action, by any person, firm or corporation, or any
agency, bureau or department of any government or any subdivision thereof, not
already obtained, is required in connection with the execution and delivery of
this Agreement by the Company or the consummation by the Company of the
transactions provided for herein and therein.

      5. Representations and Warranties of the Investors. Each Investor hereby
represents, warrants and covenants, severally and not jointly, that:

            5.1 Authorization. Investor has full power and authority to enter
into this Agreement, and such agreement constitutes the valid and legally
binding obligation of Investor, enforceable in accordance with its terms.

            5.2 Purchase Entirely for Own Account. This Agreement is made with
Investor in reliance upon Investor's representation to the Company, which by
Investor's execution of this Agreement, Investor hereby confirms, that the
Notes, Option and Underlying Securities to be received by Investor will be
acquired for investment for Investor's own account, not as a nominee or agent,
and not with a view to the resale or distribution of any part thereof, and that
Investor has no present intention of selling, granting any participation in or
otherwise distributing the same. By executing this Agreement, Investor further
represents that Investor does not have any contract, undertaking, agreement or
arrangement with any person to sell, transfer or grant participations to such
person or to any third person, with respect to any of the Notes, Option or
Underlying Securities.

                                       4
<PAGE>

           5.3 Disclosure of Information. Investor believes it has received all
the information it considers necessary or appropriate for deciding whether to
purchase the Notes. Investor further represents that he has had an opportunity
to ask questions and receive answers from the Company regarding the terms and
conditions of the offering of the Notes and the business, properties, prospects
and financial condition of the Company. The foregoing, however, does not limit
or modify the representations and warranties of the Company in Section 4 of this
Agreement or the right of Investor to rely thereon.

            5.4 Investment Experience. Investor can bear the economic risk of
its investment, and has such knowledge and experience in financial or business
matters that it is capable of evaluating the merits and risks of the investment
in the Notes and Underlying Securities.

            5.5 Accredited Investor. Investor is an "accredited investor" within
the meaning of the Securities and Exchange Commission ("SEC") Rule 501 of
Regulation D, as presently in effect; by virtue of falling within one or more of
the following: (a) a natural person whose individual net worth (or joint net
worth with his spouse) at the time of purchase exceeds $1,000,000; or (b) a
natural person who had individual income in excess of $200,000 or joint income
with his spouse in excess of $300,000 in each of the two most recent years and
reasonably expects to have individual income in excess of $200,000 or joint
income with his spouse in excess of $300,000 in the current year; (c) an
executive officer or director of the Company; or (d) an entity in which all of
the equity owners thereof are natural persons whom are "accredited" by virtue of
falling within one or more of the foregoing categories.

            5.6 Restricted Securities. Investor understands that the Notes,
Option and Underlying Securities it is purchasing are characterized as
"restricted securities" under the federal securities laws inasmuch as they are
being acquired from the Company in a transaction not involving a public offering
and that under such laws and applicable regulations such Notes, Option and
Underlying Securities may be resold without registration under the 1933 Act only
in certain limited circumstances. In the absence of an effective registration
statement covering the Notes or the Underlying Securities, as applicable, or an
available exemption from registration under the 1933 Act, the Notes and
Underlying Securities must be held indefinitely. Investor represents that it is
familiar with SEC Rule 144, as presently in effect, and understands the resale
limitations imposed thereby and by the 1933 Act, including without limitation
the Rule 144 condition that current information about the Company be available
to the public.

            5.7 Further Limitations on Disposition. Without in any way limiting
the representations set forth above, Investor shall not make any disposition of
all or any portion of the Notes, Option or Underlying Securities unless and
until the transferee has agreed in writing for the benefit of the Company to be
bound by this Section 5, and:

                  (a) there is then in effect a registration statement under the
1933 Act covering such proposed disposition and such disposition is made in
accordance with such registration statement; or

                                       5
<PAGE>

                  (b) Investor shall have notified the Company of the proposed
disposition and shall have furnished the Company with a detailed statement of
the circumstances surrounding the proposed disposition, and if requested by the
Company, the Investor shall have furnished the Company with an opinion of
counsel, reasonably satisfactory to the Company, that such disposition will not
require registration of the Note, Option or Underlying Securities, as
applicable, under the 1933 Act or any applicable state securities laws.

            5.8 Legends. It is understood that the certificates evidencing the
Notes and Underlying Securities may bear one or all of the following legends:

                  (a) "These securities have not been registered under the
Securities Act of 1933, as amended. They may not be sold, offered for sale,
pledged or hypothecated in the absence of a registration statement in effect
with respect to the securities under such Act or an opinion of counsel
satisfactory to the Company that such registration is not required."

                  (b) Any legend required by state securities laws.

            5.9 Tax Advisors. Investor has reviewed with Investor's own tax
advisors the federal, state and local tax consequences of this investment, where
applicable, and the transactions contemplated by this Agreement. Investor is
relying solely on such advisors and not on any statements or representations of
the Company (except the representations and statements of the Company set forth
in this Agreement) or any of its agents and understands that Investor (and not
the Company) shall be responsible for Investor's own tax liability that may
arise as a result of this investment or the transactions contemplated by this
Agreement, except where such liability arises as a result of a failure of a
representation of the Company set forth in this Agreement to be true or a breach
by the Company of a covenant of the Company set forth in this Agreement.

            5.10 Investor Counsel. Investor acknowledges that it has had the
opportunity to review this Agreement, the exhibits and the schedules attached
hereto and the transactions contemplated by this Agreement with Investor's own
legal counsel. Investor is relying solely on its legal counsel and not on any
statements or representations of the Company or any of the Company's agents for
legal advice with respect to this investment or the transactions contemplated by
this Agreement.

                                       6
<PAGE>

            5.11 Florida Rescission Right. Investor, if a Florida resident or a
Florida entity, acknowledges that he, she or it may at any time within three (3)
days after payment to the Company of the applicable purchase price for a Note
notify the Company, pursuant to the provisions of Section 7.4 herein, of the
Investor's intent to cancel his or her purchase. In such event, such Investor's
investment shall be canceled and of no further force or effect (and any Option
null and void), Investor shall return any Note issued to such Investor and the
Company shall promptly cause to be refunded to the Investor all consideration
paid by the Investor for the Notes in connection herewith, without interest and
without deduction.

            5.12 Residency. Investor is a resident of the state as set forth
below such Investor's signature on the signature page hereof or any applicable
Joinder to this Agreement.

      6. Registration Rights.

            6.1 Demand Registration; Limitation. At any time after April 17,
2006, the holders (the "Holders") of a majority of the shares of Common Stock
issued or issuable upon conversion of the Notes shall be entitled to deliver
written notice to the Company demanding the registration of all Registerable
Securities (as hereinafter defined) or such lesser number as the Holders may
elect. Upon the written request of such Holders, the Company shall use its
commercial reasonable best efforts to cause to be registered under the 1933 Act
all of such Registerable Shares. The Holders whom elect to participate in the
registration (or a registration pursuant to Section 6.2 below) are called
"Participating Holders." The term "Registrable Securities" shall mean shares of
the Common Stock issuable upon conversion of the Notes (whether or not issued as
part of the initial Closing or any subsequent Closing), issued in lieu of cash
interest payments under the Notes, together with any shares of Common Stock
issued or issuable by way of a stock dividend or stock split or in connection
with any recapitilization, merger, consolidation or other reorganization;
provided that the term "Registrable Securities" shall not include shares of
Common Stock issued or issuable with respect to the Notes which have been
either: (i) publicly resold pursuant to Rule 144 promulgated under the 1933 Act
or (ii) are eligible for sale under Rule 144(k) of the 1933 Act. The Holders of
the Registrable Securities may exercise the rights described in this Section 6.1
a total of one time only. Notwithstanding any demand by the Holders hereunder,
the Company shall not be required to effect any such registration, and may delay
any such registration, at anytime during which: (i) the Company has pending, or
reasonably anticipates filing within forty five (45) days of receipt of a demand
for registration hereunder, its own registration statement for the public
offering of shares of Common Stock by the Company; (ii) has pending, or has
received a notice of demand registration relating to, a registration statement
for the offer and sale of Common Stock by selling shareholders pursuant to
registration rights outstanding (or hereinafter granted) in favor of other
security holders; or (iii) the Company's Board of Directors determines, in its
good faith discretion, that such registration may have a material adverse effect
on the Company or its plans or prospects; provided that, in any of such events,
the Holders shall continue to have a demand right and the Company shall promptly
notify the Holders of the foregoing and provide the Holders with an estimate of
when they may exercise such demand registration again; and provided further that
solely in the event of clause (iii) above, (x) the Company's ability to delay
such registration shall be limited to durations of not longer than ninety (90)
days and (y) the Company shall not delay more than once during any twelve month
period.

                                       7
<PAGE>

            6.2 Piggy-Back Registration Rights. If at any time hereafter, the
Company shall prepare and file one or more registration statements under the
1933 Act, with respect to a public offering of equity or debt securities of the
Company, or of any such securities of the Company held by its security holders,
other than registration statements on forms S-4 or S-8 (or their successor
forms), the Company will include in any such registration statement such
information as is required, and such number of Registrable Securities held by
the Participating Holders thereof as may be requested by them, to permit a
public offering of the Registrable Securities so requested; provided, however,
that in the case of an underwritten offering, if, in the written opinion of the
Company's or, if pursuant to a demand registration by selling security holders,
such selling holder's, managing underwriter for such offering, the inclusion of
the Registrable Securities requested to be registered, when added to the
securities being registered by the Company or any other selling security
holder(s), would exceed the maximum amount of the Company's securities that can
be marketed without otherwise materially and adversely affecting the entire
offering, then such managing underwriter may exclude from such offering that
portion of the Registrable Securities requested to be so registered, so that the
total number of securities to be registered is within the maximum number of
shares that, in the opinion of the managing underwriter, may be marketed without
otherwise materially and adversely affect the entire offering, provided that at
least a pro rata amount of the securities that otherwise were proposed to be
registered for other stockholders (but not the Company and other than with
respect to securities registered pursuant to demand registration rights if such
securities are otherwise included in the underwriting) is also excluded. In the
event of such a proposed registration, the Company shall furnish the then
registered holders of Registrable Securities with not less than twenty (20)
days' written notice prior to the proposed date of filing of such registration
statement. Such notice shall continue to be given by the Company to registered
holders of Registrable Securities, with respect to subsequent registration
statements filed by the Purchaser, until such time as all of the Registrable
Securities have been registered or may be sold without registration under the
Act or applicable state securities laws and regulations, and without limitation
as to volume pursuant to Rule 144 of the 1933 Act. The holders of Registrable
Securities shall exercise the rights provided for herein by giving written
notice to the Company, within fifteen (15) days of receipt of the Company's
notice of its intention to file a registration statement. In the event the
offering involves an underwritten offering, the Participating Holders shall also
execute, and be a party to, the underwriting agreement of the Company or other
selling security holders.

            6.3 Furnish Information. It shall be a condition precedent to the
obligations of the Company to take any action pursuant to this Agreement with
respect to the Registrable Securities that each of the Participating Holders
furnish to the Company such information regarding itself, the Registrable
Securities held by it, and the intended method of disposition of such securities
as shall be required to effect the registration of the Registrable Securities.

            6.4 Expenses of Registration. The Company shall bear and pay all
expenses incurred in connection with any registration, filing or qualification
of Registrable Securities with respect to the registrations pursuant to Section
6.1 and 6.2 for the Investors, including without limitation all registration,
filing and qualification fees, printers' and accounting fees relating or
apportionable thereto, and, if connection with a demand registration pursuant to
Section 6.1 hereof, the fees and disbursements of one counsel appointed by the
Participating Holders. The Participating Holders shall be responsible for
payment of any underwriter's or broker's fee or commission with respect to the
sale of their Registerable Securities.

                                       8
<PAGE>

            6.5 Registration Procedures. Whenever the Holders of Registrable
Securities have requested that any Registrable Securities be registered pursuant
to this Agreement, the Company shall use its best efforts in good faith to
effect the registration and the sale of such Registrable Securities in
accordance with the intended method of disposition thereof, and in furtherance
hereof, the Company shall as expeditiously as possible:

                  (a) prepare and file with the Securities and Exchange
Commission a registration statement with respect to such Registrable Securities
and use its best efforts in good faith to cause such registration statement to
become and remain effective; provided, that before filing a registration
statement or prospectus or any amendments or supplements thereto, the Company
shall furnish to the counsel selected by the Participating Holders of a majority
of the Registrable Securities covered by such registration statement copies of
all such documents proposed to be filed, which documents shall be subject to the
review and comment of such counsel;

                  (b) notify each Participating Holder of the effectiveness of
each registration statement filed hereunder and prepare and file with the
Securities and Exchange Commission such amendments and supplements to such
registration statement and the prospectus used in connection therewith as may be
necessary to keep such registration statement effective for a period of not less
than 180 days and comply with the provisions of the 1933 Act with respect to the
disposition of all securities covered by such registration statement during such
period in accordance with the intended methods of disposition by the sellers
thereof set forth in such registration statement;

                  (c) furnish to each Participating Holder such number of copies
of such registration statement, each amendment and supplement thereto (in each
case including all exhibits thereto), the prospectus included in such
registration statement (including each preliminary prospectus) and such other
documents as such seller may reasonably request in order to facilitate the
disposition of the Registrable Securities owned by such Holder;

                  (d) use its best efforts in good faith to register or qualify
such Registrable Securities under such other securities or blue sky laws of such
jurisdictions as any Participating Holder reasonably requests and do any and all
other acts and things which may be reasonably necessary or advisable to enable
such seller to consummate the disposition in such jurisdictions of the
Registrable Securities owned by such Holder (provided that the Company shall not
be required to (i) qualify generally to do business in any jurisdiction where it
would not otherwise be required to qualify but for this subsection, (ii) subject
itself to taxation in any such jurisdiction or (iii) consent to general service
of process in any such jurisdiction);

                                       9
<PAGE>

                  (e) notify each Participating Holder, at any time when a
prospectus relating thereto is required to be delivered under the 1933 Act, of
the happening of any event as a result of which the prospectus included in such
registration statement contains an untrue statement of a material fact or omits
any fact necessary to make the statements therein not misleading, and, at the
request of any such seller or by its own initiative, the Company shall prepare a
supplement or amendment to such prospectus so that, as thereafter delivered to
the purchasers of such Registrable Securities, such prospectus shall not contain
an untrue statement of a material fact or omit to state any fact necessary to
make the statements therein not misleading;

                  (f) cause all such Registrable Securities to be listed or
admitted to trading on each securities exchange on which securities issued by
the Company are then listed or admitted for trading or, if not so listed or
admitted for trading, then on at least one securities exchange or quotation
system on which securities of companies similar to the Company are then listed
or admitted for trading, and, if admitted for trading on the Over the Counter
Bulletin Board or BBX, use its best efforts in good faith (i) to either (x)
secure designation of all such Registrable Securities covered by such
registration statement, if and to the extent eligible for such designation, as a
NASDAQ "national market system security" within the meaning of Rule 11Aa2-1 of
the Securities and Exchange Commission or (y) secure trading on the NASDAQ
"SmallCap" market and, without limiting the generality of the foregoing, and
(ii) to arrange for at least two market makers to register as such with respect
to such Registrable Securities with the NASD;

                  (g) furnish to each Participating Holder a signed counterpart,
addressed to such Participating Holder, of (i) an opinion of counsel for the
Company, dated the effective date of the registration statement, and (ii) a
"comfort" letter signed by the independent public accountants who have certified
the Company's financial statements included in the registration statement,
covering substantially the same matters with respect to the registration
statement (and the prospectus included therein) and (in the case of the comfort
letter, with respect to events subsequent to the date of the financial
statements), as are customarily covered (at the time of such registration) in
opinions of issuer's counsel and in comfort letters delivered to the
underwriters in underwritten public offerings of securities. If and to the
extent that any registration relates to an underwritten public offering, such
opinion and comfort letter shall be sufficient if it is in the form acceptable
to the managing underwriter thereof.

                  (h) provide a transfer agent and registrar for all such
Registrable Securities not later than the effective date of such registration
statement;

                  (i) enter into such customary agreements (including
underwriting agreements in customary form) and take all such other actions as
the Participating Holders of a majority of the Registrable Securities being sold
or the underwriters, if any, reasonably request in order to expedite or
facilitate the disposition of such Registrable Securities;

                                       10
<PAGE>

                  (j) in the event of the issuance of any stop order suspending
the effectiveness of a registration statement, or of any order suspending or
preventing the use of any related prospectus or suspending the qualification of
any Common Stock included in such registration statement for sale in any
jurisdiction, the Company shall use its best efforts in good faith promptly to
obtain the withdrawal of such order.

            6.6 Selection of Underwriter. In the event of a demand registration
pursuant to Section 6.1 hereof, the holders of a majority of the Registrable
Securities initially requesting registration hereunder shall have the right to
select the investment banker(s) and manager(s) to administer the offering,
subject to the Company's approval which shall not be unreasonably withheld or
delayed.

            6.7 Indemnification. In the event any Registrable Securities are
included in a registration statement under this Section 6:

                  (a) The Company will indemnify and hold harmless the
Participating Holders, the partners or officers, directors and shareholders of
the Participating Holders, legal counsel and accountants for the Participating
Holders, against any losses, claims, damages or liabilities (joint or several)
to which they may become subject under the 1933 Act, the 1934 Act or any state
securities laws, insofar as such losses, claims, damages, or liabilities (or
actions in respect thereof) arise out of or are based upon any of the following
statements, omissions or violations (collectively a "Violation"): (i) any untrue
statement or alleged untrue statement of a material fact contained in such
registration statement, including any preliminary prospectus or final prospectus
contained therein or any amendments or supplements thereto, (ii) the omission or
alleged omission to state therein a material fact required to be stated therein,
or necessary to make the statements therein not misleading, or (iii) any
violation or alleged violation by the Company of the 1933 Act, the 1934 Act, any
state securities laws or any rule or regulation promulgated under the 1933 Act,
the 1934 Act or any state securities laws. The Company will reimburse each
Participating Holder for any legal or other expenses reasonably incurred by it
in connection with investigating or defending any such loss, claim, damage,
liability or action; provided, however, that the indemnity agreement contained
in this subsection 6.7 (a) shall not apply to amounts paid in settlement of any
such loss, claim, damage, liability or action if such settlement is effected
without the consent of the Company (which consent shall not be unreasonably
withheld), nor shall the Company be liable for any such loss, claim, damage,
liability or action to the extent that it arises out of or is based upon a
Violation that occurs in reliance upon and in conformity with written
information furnished expressly for use in connection with such registration by
such Participating Holder; provided further, however, that the foregoing
indemnity agreement with respect to any preliminary prospectus shall not inure
to the benefit a Participating Holder, from whom the person asserting any such
losses, claims, damages or liabilities purchased shares in the offering, if a
copy of the prospectus (as then amended or supplemented if the Company shall
have furnished any amendments or supplements thereto) was not sent or given by
or on behalf of such Participating Holder to such person, if required by law so
to have been delivered, at or prior to the written confirmation of the sale of
the shares to such person, and if the prospectus (as so amended or supplemented)
would have cured the defect giving rise to such loss, claim, damage or
liability.

                                       11
<PAGE>

                  (b) Each Participating Holder will indemnify and hold harmless
the Company, each of its directors, each of its officers who has signed the
registration statement, each person, if any, who controls the Company within the
meaning of the 1933 Act, legal counsel and accountants for the Company and any
underwriter, against any losses, claims, damages or liabilities (joint or
several) to which any of the foregoing persons may become subject under the 1933
Act, the 1934 Act or any state securities laws, insofar as such losses, claims,
damages or liabilities (or actions in respect thereto) arise out of or are based
upon any Violation, in each case to the extent (and only to the extent) that
such Violation occurs in reliance upon and in conformity with written
information furnished by such Participating Holder expressly for use in
connection with such registration; and such Participating Holder will reimburse
any person intended to be indemnified pursuant to this subsection, for any legal
or other expenses reasonably incurred by such person in connection with
investigating or defending any such loss, claim, damage, liability or action;
provided, however, that the indemnity agreement contained in this subsection
6.7(b) shall not apply to amounts paid in settlement of any such loss, claim,
damage, liability or action if such settlement is effected without the consent
of such Participating Holder (which consent shall not be unreasonably withheld).

                  (c) Promptly after receipt by an indemnified party under this
Section 6.7 of notice of the commencement of any action (including any action by
a governmental authority), such indemnified party (the "Indemnified Party")
will, if a claim in respect thereof is to be made against any indemnifying party
(the "Indemnifying Party") under this Section 6.7, deliver to the Indemnifying
Party a written notice of the commencement thereof and the Indemnifying Party
shall have the right to participate in, and, to the extent the Indemnifying
Party so desires, jointly with any other indemnifying party similarly noticed,
to assume the defense thereof with counsel mutually satisfactory to the parties;
provided, however, that an Indemnified Party (together with all other
indemnified parties that may be represented without conflict by one counsel)
shall have the right to retain one separate counsel, with the fees and expenses
to be paid by the Indemnifying Party, if representation of such Indemnified
Party by the counsel retained by the Indemnifying Party would be inappropriate
due to actual or potential differing interests between such Indemnified Party
and any other party represented by such counsel in such proceeding. No
Indemnifying Party shall, without the consent of the Indemnified Party, consent
to entry of any judgment or enter into any settlement of any such action which
does not include as an unconditional term thereof the giving by the claimant or
plaintiff to such Indemnified Party of a complete and full release from all
liability in respect of such claim or litigation. No Indemnified Party shall
consent to entry of any judgment or enter into any settlement of any such action
the defense of which has been assumed by an Indemnifying Party without the
consent of such Indemnifying Party.

                  (d) If the indemnification provided for in this Section 6.7 is
held by a court of competent jurisdiction to be unavailable to an Indemnified
Party with respect to any loss, liability, claim, damage or expense referred to
herein, then the Indemnifying Party, in lieu of indemnifying such Indemnified
Party hereunder, shall contribute to the amount paid or payable by such
Indemnified Party as a result of such loss, liability, claim, damage or expense
in such proportion as is appropriate to reflect the relative fault of the
Indemnifying Party on the one hand and of the indemnified party on the other in
connection with the statements or omissions that resulted in such loss,
liability, claim, damage or expense, as well as any other relevant equitable
considerations. The relative fault of the Indemnifying Party and of the
Indemnified Party shall be determined by reference to, among other things,
whether the untrue or alleged untrue statement of a material fact or the
omission to state a material fact relates to information supplied by the
Indemnifying Party or by the Indemnified Party and the parties' relative intent,
knowledge, access to information, and opportunity to correct or prevent such
statement or omission.

                                       12
<PAGE>

                  (e) No Person guilty of fraudulent misrepresentation (within
the meaning of Section 11(f) of the 1933 Act) shall be entitled to contribution
from any person who was not guilty of such fraudulent misrepresentation.
Notwithstanding anything to the contrary in this Section 6.7, no indemnified
party shall be required, pursuant to this Section 6.7, to contribute any amount
in excess of the net proceeds received by such indemnifying party from the sale
of securities in the offering to which the losses, claims, damages, liabilities
or expenses of the indemnified party relate.

            6.8 Successors and Assigns. The covenants and agreements in this
Section 6 by or on behalf of any of the parties hereto shall bind and inure to
the benefit of the respective successors and assigns of the parties hereto
whether so expressed or not. In addition, whether or not any express assignment
has been made, the provisions of this Agreement which are for the benefit of
purchasers or holders of Registrable Securities are also for the benefit of, and
enforceable by, any subsequent holder of Registrable Securities.

      7. Miscellaneous

            7.1 Successors and Assigns. Except as otherwise provided herein, the
terms and conditions of this Agreement shall inure to the benefit of and be
binding upon the respective successors and assigns of the parties (including
transferees of the Shares). Nothing in this Agreement, express or implied, is
intended to confer upon any party, other than the parties hereto or their
respective successors and assigns, any rights, remedies, obligations or
liabilities under or by reason of this Agreement, except as expressly provided
in this Agreement.

            7.2 Governing Law. This Agreement shall be governed by and construed
under the laws of the State of Delaware without giving effect to its conflict of
laws provisions.

            7.3 Titles and Subtitles. The titles and subtitles used in this
Agreement are used for convenience only and are not to be considered in
construing or interpreting this Agreement.

            7.4 Notices. All notices required or permitted hereunder shall be in
writing and shall be deemed effectively given: (a) upon personal delivery to the
party to be notified, (b) when sent by confirmed telex or facsimile if sent
during normal business hours of the recipient; if not, then on the next business
day, (c) five (5) business days after having been sent by registered or
certified mail, return receipt requested, postage prepaid, or (d) one (1) day
after deposit with a nationally recognized overnight courier, specifying next
day delivery, with written verification of receipt. All communications shall be
sent to the party to be notified at the address as set forth on the signature
page or exhibit pages hereof or at such other address as such party may
designate by ten (10) days advance written notice to the other parties hereto.

                                       13
<PAGE>

            7.5 Finder's Fees. Each party represents that it neither is nor will
be obligated for any finders' fee or commission in connection with this
transaction. Each Investor, severally and not jointly, shall indemnify and hold
harmless the Company from any liability for any commission or compensation in
the nature of a finders' fee (and the costs and expenses of defending against
such liability or asserted liability) for which Investor or any of its officers,
partners, employees or representatives is responsible. The Company shall
indemnify and hold harmless each Investor from any liability for any commission
or compensation in the nature of a finders' fee (and the costs and expenses of
defending against such liability or asserted liability) for which the Company or
any of its officers, employees or representatives is responsible.

            7.6 Amendments and Waivers. Any term of this Agreement may be
amended and the observance of any term of this Agreement may be waived (either
generally or in a particular instance and either retroactively or
prospectively), only with the written consent of the Company and the holders of
at least a majority of the then outstanding principal amount of all of the Notes
(for purposes of this Section, as to any Note which has been converted in whole
or in part into shares of Common Stock, the amount so converted shall be treated
as outstanding principal). Any amendment or waiver effected in accordance with
this paragraph shall be binding upon the Investors, and each future holder of
the Notes or Shares and the Company, provided that no such amendment shall be
binding on a holder that does not consent thereto to the extent such amendment
treats such party substantially differently than any party that does consent
thereto.

            7.7 Severability. If one or more provisions of this Agreement are
held to be unenforceable under applicable law, such provision shall be excluded
from this Agreement and the balance of the Agreement shall be interpreted as if
such provision were so excluded and shall be enforceable in accordance with its
terms.

            7.8 Entire Agreement. This Agreement and the documents referred to
herein constitute the entire agreement among the parties and no party shall be
liable or bound to any other party in any manner by any warranties,
representations or covenants except as specifically set forth herein or therein.

            7.9 Counterparts. This Agreement may be executed in two or more
counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument.

                                       14
<PAGE>

            7.10 Interpretation. Unless the context of this Agreement clearly
requires otherwise, (a) references to the plural include the singular, the
singular the plural, the part the whole, (b) references to any gender include
all genders, (c) "including" has the inclusive meaning frequently identified
with the phrase "but not limited to" and (d) references to "hereunder" or
"herein" relate to this Agreement.

            7.11 Independent Nature of Investors' Obligations. The obligations
of each Investor are several and not joint with the obligations of any other
Investor.

                    [Signatures appear on the following page]

                                       15
<PAGE>

      IN WITNESS WHEREOF, the parties have caused this Agreement to be duly
executed and delivered as of the date provided above.

                                 theglobe.com, inc.

                                 By _______________________________
                                 Name:
                                 Title:

                                 INVESTORS:

                                 E&C Capital Partners LLLP
                                 By: E&C Capital Ventures, Inc., General Partner

                                 By: ______________________________
                                 Name: ________________

                                 Address: ________________________
                                 _________________________________
                                 _________________________________

                                 E&C Capital Partners II, Ltd.
                                 By: E&C Capital Ventures, Inc., General Partner

                                 By: ______________________________
                                 Name: ________________

                                 Address: _________________________
                                 _________________________________
                                 _________________________________

                                       16
<PAGE>

                       Joinder To Note Purchase Agreement

The undersigned does hereby join in that certain Note Purchase Agreement dated
as of April __, 2005 (the "Agreement") as an additional Investor and does hereby
agree to the terms thereof.

Dated: _________________, 2005

                                 INVESTOR:
                                 _________________________________
                                 Name: ________________

                                 Address: ________________________
                                 _________________________________
                                 _________________________________

                                       17
<PAGE>

Schedule A

                          Investors and Option Holders

                         (may be updated by the Company
                  from time to time consistent with Section 2)

                                                               Principal Amount
Name of Purchaser/Address      Principal Amount of Note          of Option
-------------------------      ------------------------       -----------------

E&C Capital Partners LLLP              $750,000                   $1,250,000
c/o theglobe.com, inc.
110 E. Broward Boulevard
14th Floor
Fort Lauderdale, FL  33301
Attn:  Edward A Cespedes

E&C Capital Partners II, Ltd.          $750,000                   $1,250,000
c/o theglobe.com, inc.
110 E. Broward Boulevard
14th Floor
Fort Lauderdale, FL  33301
Attn:  Edward A Cespedes

                                       18
<PAGE>

                                    EXHIBIT A

                       Form of Convertible Promissory Note

<PAGE>

                                    EXHIBIT B

                           Form of Security Agreement

<PAGE>

                                    EXHIBIT C

                                Form of GuarantyPATIENT SAFETY TECHNOLOGIES, INC.
                             SUBSCRIPTION AGREEMENT

      SUBSCRIPTION AGREEMENT ("Subscription Agreement") made as of this 22nd day
of April 2005 between Patient Safety Technologies, Inc., a Delaware corporation
with offices located at 100 Wilshire Boulevard, Suite 1500, Santa Monica,
California 90401 (the "Company"), and the undersigned (the "Subscriber").

      WHEREAS, pursuant to Section 4(2) of the Securities Act of 1933, as
amended (the "Securities Act"), and Rule 506 promulgated thereunder, the Company
desires to sell and the Subscriber desires to purchase 20,000 shares of the
Company's common stock and warrants to purchase 20,000 shares of the Company's
common stock in a private placement (the "Offering") on the terms and conditions
set forth herein;

      NOW, THEREFORE, for and in consideration of the premises and the mutual
covenants hereinafter set forth, the parties hereto do hereby agree as follows:

      I.    SUBSCRIPTION FOR SECURITIES; REPRESENTATIONS BY AND COVENANTS OF
            SUBSCRIBER

            1.1 Subscription for Securities. Subject to the terms and conditions
hereinafter set forth, the Subscriber hereby subscribes for and agrees to
purchase from the Company 20,000 shares of the Company's common stock, $.33 par
value ("Shares"), at a purchase price of $5.00 per share and the Company agrees
to sell such Shares to the Subscriber for said purchase price. For each two
Shares purchased by Subscriber, the Company shall issue Subscriber: (a) one
non-callable warrant with an exercise price of $6.05, exercisable for a period
of five years, in the form attached hereto as Exhibit A; and (b) one callable
warrant with an exercise price of $6.05, exercisable for a period of five years,
in the form attached hereto as Exhibit B ("Warrants" and together with the
Shares, the "Securities").

            1.2 Reliance on Exemptions. The Subscriber acknowledges that the
Offering has not been reviewed by the United States Securities and Exchange
Commission (the "SEC") or any state agency because it is intended to be a
nonpublic offering exempt from the registration requirements of the Securities
Act and state securities laws. The Subscriber understands that the Company is
relying in part upon the truth and accuracy of, and the Subscriber's compliance
with the representations, warranties, agreements, acknowledgments and
understandings of the Subscriber set forth herein in order to determine the
availability of such exemptions and the eligibility of the Subscriber to acquire
the Securities.

            1.3 Investment Purpose. The Subscriber represents that the
Securities are being purchased for its own account, for investment purposes only
and not for distribution or resale to others in contravention of the
registration requirements of the Securities Act. The Subscriber agrees that it
will not sell or otherwise transfer the Securities unless they are registered
under the Securities Act or unless an exemption from such registration is
available.

            1.4 Accredited Investor. The Subscriber represents and warrants that
it is an "accredited investor" as such term is defined in Rule 501 of Regulation

<PAGE>

D promulgated under the Securities Act, and that it is able to bear the economic
risk of any investment in the Securities. The Subscriber further represents and
warrants that the information furnished in the accompanying accredited investor
questionnaire, which is attached hereto as Exhibit C, is accurate and complete
in all material respects.

            1.5 Risk of Investment. The Subscriber recognizes that the purchase
of the Securities involves a high degree of risk in that: (a) an investment in
the Company is highly speculative and only investors who can afford the loss of
their entire investment should consider investing in the Company and the
Securities; (b) transferability of the Securities is limited; and (c) the
Company may require substantial additional funds to operate its business and
subsequent equity financings will dilute the ownership and voting interests of
Subscriber.

            1.6 Prior Investment Experience. The Subscriber acknowledges that it
has prior investment experience and that it recognizes the highly speculative
nature of this investment.

            1.7 Information. The Subscriber acknowledges careful review of this
Subscription Agreement as well as the Company's filings with the Securities and
Exchange Commission, as required pursuant to the Securities and Exchange Act of
1934, which are available on the Internet at www.sec.gov (collectively, the
"Offering Documents"), all of which the undersigned acknowledges have been
provided to the undersigned. The undersigned has been given the opportunity to
ask questions of, and receive answers from, the Company concerning the terms and
conditions of this Offering and the Offering Documents and to obtain such
additional information, to the extent the Company possesses such information or
can acquire it without unreasonable effort or expense, necessary to verify the
accuracy of same as the undersigned reasonably desires in order to evaluate the
investment. The undersigned understands the Offering Documents, and the
undersigned has had the opportunity to discuss any questions regarding any of
the Offering Documents with its counsel or other advisor. Notwithstanding the
foregoing, the only information upon which the undersigned has relied is that
set forth in the Offering Documents. The undersigned has received no
representations or warranties from the Company, its employees, agents or
attorneys in making this investment decision other than as set forth in the
Offering Documents. The undersigned does not desire to receive any further
information.

            1.8 No Representations. The Subscriber hereby represents that,
except as expressly set forth in the Offering Documents, no representations or
warranties have been made to the Subscriber by the Company or any agent,
employee or affiliate of the Company, and in entering into this transaction the
Subscriber is not relying on any information other than that contained in the
Offering Documents and the results of independent investigation by the
Subscriber.

            1.9 Tax Consequences. The Subscriber acknowledges that the Offering
may involve tax consequences and that the contents of the Offering Documents do
not contain tax advice or information. The Subscriber acknowledges that it must
retain its own professional advisors to evaluate the tax and other consequences
of an investment in the Securities.

            1.10 Transfer or Resale. The Subscriber understands and hereby
acknowledges that the Company is under no obligation to register the Securities

                                       2
<PAGE>

under the Securities Act except as contained herein. The Subscriber consents
that the Company may, if it desires, permit the transfer of the Securities out
of the Subscriber's name only when the Subscriber's request for transfer is
accompanied by an opinion of counsel reasonably satisfactory to the Company that
neither the sale nor the proposed transfer results in a violation of the
Securities Act or any applicable state "blue sky" laws.

            1.11 Legends. The Subscriber understands that the certificates
representing the Securities, until such time as they have been registered under
the Securities Act, shall bear a restrictive legend in substantially the
following form (and a stop-transfer order may be placed against transfer of such
certificates or other instruments):

      THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED
      UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE
      SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD,
      TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE
      REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF
      1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS, OR (B) AN OPINION
      OF COUNSEL, IN A REASONABLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT
      REQUIRED UNDER SAID ACT OR APPLICABLE STATE SECURITIES LAWS, OR (II)
      UNLESS SOLD PURSUANT TO RULE 144 UNDER SAID ACT.

            The legend set forth above shall be removed and the Company shall
issue a certificate without such legend to the holder of the Securities upon
which it is stamped, if (a) such Securities are being sold pursuant to a
registration statement under the Securities Act, (b) such holder delivers to the
Company an opinion of counsel, in a reasonably acceptable form, to the Company
that a disposition of the Securities is being made pursuant to an exemption from
such registration, or (c) such holder provides the Company with reasonable
assurance that a disposition of the Securities may be made pursuant to the Rule
144 under the Securities Act without any restriction as to the number of
securities acquired as of a particular date that can then be immediately sold.

            1.12 No General Solicitation. The Subscriber represents that the
Subscriber was not induced to invest by any form of general solicitation or
general advertising including, but not limited to, the following: (a) any
advertisement, article, notice or other communication published in any
newspaper, magazine or similar media or broadcast over the news or radio; and
(b) any seminar or meeting whose attendees were invited by any general
solicitation or advertising.

            1.13 Validity; Enforcement. If the Subscriber is a corporation,
partnership, trust or other entity, the Subscriber represents and warrants that:
(a) it is authorized and otherwise duly qualified to purchase and hold the
Securities; and (b) that this Subscription Agreement has been duly and validly
authorized, executed and delivered and constitutes the legal, binding and

                                       3
<PAGE>

enforceable obligation of the undersigned. If the Subscriber is an individual,
the Subscriber represents and warrants that this Subscription Agreement has been
duly and validly executed and delivered and constitutes the legal, binding and
enforceable obligation of the undersigned.

            1.14 Address. The Subscriber hereby represents that the address of
the Subscriber furnished by the Subscriber at the end of this Subscription
Agreement is the undersigned's principal residence if the Subscriber is an
individual or its principal business address if it is a corporation or other
entity.

            1.15 Foreign Subscriber. If the Subscriber is not a United States
person, such Subscriber hereby represents that it has satisfied itself as to the
full observance of the laws of its jurisdiction in connection with any
invitation to subscribe for the Securities or any use of this Subscription
Agreement, including: (a) the legal requirements within its jurisdiction for the
purchase of the Securities; (b) any foreign exchange restrictions applicable to
such purchase; (c) any governmental or other consents that may need to be
obtained; and (d) the income tax and other tax consequences, if any, that may be
relevant to the purchase, holding, redemption, sale or transfer of the
Securities. Such Subscriber's subscription and payment for, and its continued
beneficial ownership of the Securities, will not violate any applicable
securities or other laws of the Subscriber's jurisdiction.

      II. REPRESENTATIONS BY THE COMPANY

            The Company represents and warrants to the Subscriber, except as set
forth in the disclosure schedules attached hereto:

            2.1 Organization. The Company is duly organized and validly existing
in good standing under the laws of the jurisdiction of its organization. The
Company has full power and authority to own, operate and occupy its properties
and to conduct its business as presently conducted, and is registered or
qualified to do business and in good standing in each jurisdiction in which the
nature of the business conducted by it or the location of the properties owned
or leased by it requires such qualification and where the failure to be so
qualified would have a material adverse effect upon the Company's financial
condition (a "Material Adverse Effect"), and no proceeding has been instituted
in any such jurisdiction revoking, limiting or curtailing, or seeking to revoke,
limit or curtail, such power and authority or qualification.

            2.2 Due Authorization and Valid Issuance. The Company has all
requisite power and authority to execute, deliver and perform its obligations
under the Offering Documents, and when executed and delivered by the Company
will constitute legal, valid and binding agreements of the Company enforceable
against the Company in accordance with their terms, except as rights to
indemnity and contribution may be limited by state or federal securities laws or
the public policy underlying such laws, and except as enforceability may be
limited by applicable bankruptcy, insolvency, reorganization, moratorium or
similar laws affecting creditors' and contracting parties' rights generally, and
except as enforceability may be subject to general principles of equity
(regardless of whether such enforceability is considered in a proceeding in
equity or at law).

                                       4
<PAGE>

            2.3 Noncontravention. The execution and delivery of the Offering
Documents, the issuance and sale of the Securities under the Offering Documents,
the fulfillment of the terms of the Offering Documents, and the consummation of
the transactions contemplated thereby will not (i) conflict with or constitute a
violation of, or default (with the passage of time or otherwise) under (1) any
material bond, debenture, note or other evidence of indebtedness, lease,
contract, indenture, mortgage, deed of trust, loan agreement, joint venture or
other agreement or instrument to which the Company is a party or by which it or
any of its properties are bound, (2) the charter, bylaws or other organizational
documents of the Company or any subsidiary or (3) any law, administrative
regulation, ordinance or order of any court or governmental agency, arbitration
panel or authority applicable to the Company or its properties, except for any
such conflicts, violations or defaults that are not reasonably likely to have a
Material Adverse Effect, or (ii) result in the creation or imposition of any
lien, encumbrance, claim, security interest or restriction whatsoever upon any
of the material properties or assets of the Company or an acceleration of
indebtedness pursuant to any obligation, agreement or condition contained in any
material bond, debenture, note or any other evidence of indebtedness, indenture,
mortgage, deed of trust or any other agreement or instrument to which the
Company is a party or by which it is bound or to which any of the material
property or assets of the Company is subject. No consent, approval,
authorization or other order of, or registration, qualification or filing with,
any regulatory body, administrative agency, or other governmental body in the
United States or any other person is required for the execution and delivery of
the Offering Documents and the valid issuance and sale of the Securities to be
sold pursuant to the Offering Documents, other than such as have been made or
obtained, and except for any post-closing securities filings or notifications
required to be made under federal or state securities laws.

            2.4 No Violation. The Company is not (a) in violation of its
charter, bylaws or other organizational document; (b) in violation of any law,
administrative regulation, ordinance or order of any court or governmental
agency, arbitration panel or authority applicable to the Company, which
violation, individually or in the aggregate, would be reasonably likely to have
a Material Adverse Effect; or (c) in default (and there exists no condition
that, with the passage of time or otherwise, would constitute a default) in any
material respect in the performance of material agreement or instrument to which
the Company is a party or by which the Company is bound or by which the
properties of the Company are bound, that would be reasonably likely to have a
Material Adverse Effect. The business of the Company is not being conducted, and
shall not be conducted so long as the investors own any of the Securities, in
violation of any law, ordinance, rule, regulation, order, judgment or decree of
any governmental entity, court or arbitration tribunal, except for possible
violations the sanctions for which either singly or in the aggregate would not
have a Material Adverse Effect.

            2.5 Capitalization. Schedule 2.5 attached hereto contains a complete
and accurate description of the authorized, issued and outstanding capital stock
of the Company as of the date thereof (before giving effect to the transactions
contemplated by this Subscription Agreement). The Securities to be sold pursuant
to the Offering Documents have been duly authorized, and when issued and paid
for in accordance with the terms of the Agreements will be duly and validly

                                       5
<PAGE>

issued, fully paid and nonassessable. The outstanding shares of capital stock of
the Company have been duly and validly issued and are fully paid and
nonassessable, have been issued in compliance with all federal and state
securities laws, and were not issued in violation of any preemptive rights or
similar rights to subscribe for or purchase securities. Except as provided in
Schedule 2.5, there are no other outstanding rights (including, without
limitation, preemptive rights), warrants or options to acquire, or instruments
convertible into or exchangeable for, any unissued shares of capital stock or
other equity interest in the Company, or any contract, commitment, agreement,
understanding or arrangement of any kind to which the Company is a party or of
which the Company has knowledge relating to the issuance or sale of any capital
stock of the Company, any such convertible or exchangeable securities, or any
such rights, warrants or options. Without limiting the foregoing, except as
contemplated in connection with the Offering and except as provided in Schedule
2.5, no preemptive right, co-sale right, right of first refusal, registration
right, or other similar right exists with respect to the Securities or the
issuance and sale thereof (other than any such rights for which the Company has
obtained waivers in respect thereof). Except as provided in Schedule 2.5, there
are no stockholders agreements, voting agreements or other similar agreements
with respect to the common stock of the Company to which the Company is a party
or, to the knowledge of the Company, between or among any of the Company's
stockholders. The Company does not have any so-called stockholder rights plan or
"poison pill" and there are no "shark-repellant" charter or bylaw provisions or
so-called "state antitakeover" statutes applicable, in any case, to all or any
portion of the transactions contemplated by the Offering Documents, including,
without limitation, issuance of the Securities.

            2.6 Legal Proceedings. Except as otherwise disclosed in the
Company's filings with the Securities and Exchange Commission, there is no
action, suit, proceeding, or to the knowledge of the Company, inquiry or
investigation before or by any court, public board, governmental agency or
authority, or self-regulatory organization or body pending or, to the knowledge
of the Company, threatened against or affecting the Company or any of its
directors or officers in their capacities as such, wherein an unfavorable
decision, ruling or finding would have a Material Adverse Effect or would
adversely affect the Offering or that would adversely affect the validity or
enforceability of, or the authority or ability of the Company to consummate the
Offering.

            2.7 Internal Accounting Controls. The Company and each of its
subsidiaries maintains a system of internal accounting controls sufficient to
provide reasonable assurance that (i) transactions are executed in accordance
with management's general or specific authorizations, (ii) transactions are
recorded as necessary to permit preparation of financial statements in
conformity with generally accepted accounting principles and to maintain asset
accountability, (iii) access to assets is permitted only in accordance with
management's general or specific authorization, and (iv) the recorded
accountability for assets is compared with the existing assets at reasonable
intervals and appropriate action is taken with respect to any differences. The
Company has established disclosure controls and procedures for the Company and
designed such disclosure controls and procedures to ensure that material
information relating to the Company, including its subsidiaries, is made known

                                       6
<PAGE>

to the certifying officers by others within those entities. The Company's
certifying officers evaluated the effectiveness of the Company's controls and
procedures as required by the rules of the Securities and Exchange Commission.

            2.8 Governmental Permits, etc. The Company has all necessary
franchises, licenses, certificates and other authorizations from any foreign,
federal, state or local government or governmental agency, department, or body
that are currently necessary for the operation of the business of the Company as
currently conducted, except where the failure to currently possess could not
reasonably be expected to have a Material Adverse Effect.

            2.9 Intellectual Property. (i) The Company owns or possesses
sufficient rights to use all material patents, patent rights, trademarks,
copyrights, licenses, inventions, trade secrets, trade names and know-how
(collectively, "Intellectual Property") as owned or possessed by it, or that are
necessary for the conduct of its business as now conducted or as proposed to be
conducted, except where the failure to currently own or possess would not have a
Material Adverse Effect, (ii) the Company has not received any notice of, or has
any knowledge of, any asserted infringement by the Company of, any rights of a
third party with respect to any Intellectual Property that, individually or in
the aggregate, would have a Material Adverse Effect, and (iii) the Company has
not received any notice of, or has no knowledge of, infringement by a third
party with respect to any Intellectual Property rights of the Company that,
individually or in the aggregate, would have a Material Adverse Effect.

            2.10 Financial Statements. The financial statements of the Company
included in the Company's filings with the Securities and Exchange Commission
have been prepared in accordance with U.S. generally accepted accounting
principles, consistently applied, during the periods involved (except as may be
otherwise indicated in such financial statements or the notes thereto, or in the
case of unaudited interim statements, to the extent they do not include
footnotes or are condensed or summary statements) and fairly present in all
material respects the consolidated financial position of the Company and its
consolidated subsidiaries as of the dates thereof and the consolidated results
of their operations and cash flows for the periods then ended (subject, in the
case of unaudited statements, to normal, immaterial year-end audit adjustments).
Except as set forth in the financial statements of the Company included in the
Company's filings with the Securities and Exchange Commission, the Company has
no liabilities, contingent or otherwise, other than (i) liabilities incurred
subsequent to the date of such financial statements in the ordinary course of
business consistent with past practice and (ii) obligations under contracts and
commitments incurred in the ordinary course of business and not required under
U.S. generally accepted accounting principles to be reflected in such financial
statements, in each case that, individually or in the aggregate, are not
material to the financial condition, business, operations, properties, operating
results or prospects of the Company and its subsidiaries taken on a whole.

            2.11 Disclosure. None of the representations and warranties of the
Company appearing in the Offering Documents, when considered together as a
whole, contains, or on any closing date will contain, any untrue statement of a
material fact or omits, or on any closing date will omit to state any material
fact required to be stated herein or therein in order for the statements herein

                                       7
<PAGE>

or therein, in light of the circumstances under which they were made, not to be
misleading.

      III. REGISTRATION RIGHTS

            3.1 The Company agrees that if, at any time, and from time to time,
after the date hereof the Board of Directors of the Company (the "Board") shall
authorize the filing of a registration statement under the Securities Act (other
than a registration statement on Form S-8, Form S-4 or any other form that does
not include substantially the same information as would be required in a form
for the general registration of securities) in connection with the proposed
offer of any of its securities by it or any of its stockholders, the Company
shall: (A) promptly notify the Subscriber that such registration statement will
be filed and that the Securities then held by the Subscriber will be included in
such registration statement; (B) cause such registration statement to cover all
of such Securities issued to the Subscriber; (C) use best efforts to cause such
registration statement to become effective as soon as practicable; and (D) take
all other reasonable action necessary under any federal or state law or
regulation of any governmental authority to permit all such Securities that have
been issued to such holder to be sold or otherwise disposed of, and will
maintain such compliance with each such federal and state law and regulation of
any governmental authority for the period necessary for such holder to promptly
effect the proposed sale or other disposition. Notwithstanding any other
provision of this Section 3.1, the Company may at any time, abandon or delay any
registration commenced by the Company. In the event of such an abandonment by
the Company, the Company shall not be required to continue registration of the
Securities, the Holder shall retain the right to request inclusion of shares as
set forth above.

      IV. MISCELLANEOUS

            4.1 Notice. Any notices, consents, waivers or other communications
required or permitted to be given under the terms of this Subscription Agreement
must be in writing and will be deemed to have been delivered: (a) upon receipt,
when delivered personally, (b) upon receipt, when sent by facsimile (provided
confirmation of transmission is mechanically or electronically generated and
kept on file by the sending party), or (c) one (1) business day after deposit
with an overnight courier service, in each case properly addressed to the party
to receive the same. The addresses and facsimile numbers for such communications
shall be:

            If to the Company:

            Patient Safety Technologies, Inc.
            100 Wilshire Boulevard, 15th Floor, Suite 1500
            Santa Monica, CA 90401
            Attn: Milton "Todd" Ault III
            Telephone: (310) 752-1416
            Facsimile: (310) 752-148

                                       8
<PAGE>

            With a copy to (which shall not constitute notice):

            Sichenzia Ross Friedman Ference LLP
            1065 Avenue of the Americas
            New York, New York 10018
            Attn:  Marc J. Ross, Esq.
            Telephone: (212) 930-9700
            Facsimile: (212) 930-9725

            If to the Subscriber, to its address and facsimile number set forth
at the end of this Subscription Agreement, or to such other address and/or
facsimile number and/or to the attention of such other person as specified by
written notice given to the Company five (5) days prior to the effectiveness of
such change. Written confirmation of receipt (a) given by the recipient of such
notice, consent, waiver or other communication, (b) mechanically or
electronically generated by the sender's facsimile machine containing the time,
date, recipient facsimile number and an image of the first page of such
transmission, or (c) provided by an overnight courier service shall be
rebuttable evidence of personal service, receipt by facsimile or receipt from an
overnight courier service in accordance with clause (a), (b) or (c) above,
respectively.

            4.2 Entire Agreement; Amendment. This Subscription Agreement
supersedes all other prior oral or written agreements between the Subscriber,
the Company, their affiliates and persons acting on their behalf with respect to
the matters discussed herein, and this Subscription Agreement and the
instruments referenced herein contain the entire understanding of the parties
with respect to the matters covered herein and therein and, except as
specifically set forth herein or therein, neither the Company nor the Subscriber
makes any representation, warranty, covenant or undertaking with respect to such
matters. No provision of this Subscription Agreement may be amended or waived
other than by an instrument in writing signed by the Company and the holders of
at least a majority of the Securities then outstanding (determined on an as
exercised to common stock basis) (or if prior to the closing, the Subscribers
purchasing at least a majority of the Securities to be purchased at the
closing). No such amendment shall be effective to the extent that it applies to
less than all of the holders of the Securities then outstanding.

            4.3 Severability. If any provision of this Subscription Agreement
shall be invalid or unenforceable in any jurisdiction, such invalidity or
unenforceability shall not affect the validity or enforceability of the
remainder of this Subscription Agreement in that jurisdiction or the validity or
enforceability of any provision of this Subscription Agreement in any other
jurisdiction.

            4.4 Governing Law; Jurisdiction; Waiver of Jury Trial. All questions
concerning the construction, validity, enforcement and interpretation of this
Subscription Agreement shall be governed by the internal laws of the State of
California, without giving effect to any choice of law or conflict of law
provision or rule (whether of the State of California or any other
jurisdictions) that would cause the application of the laws of any jurisdictions
other than the State of California. Each party hereby irrevocably submits to the

                                       9
<PAGE>

non-exclusive jurisdiction of the state and federal courts sitting in Los
Angeles County, California for the adjudication of any dispute hereunder or in
connection herewith or with any transaction contemplated hereby or discussed
herein, and hereby irrevocably waives, and agrees not to assert in any suit,
action or proceeding, any claim that it is not personally subject to the
jurisdiction of any such court, that such suit, action or proceeding is brought
in an inconvenient forum or that the venue of such suit, action or proceeding is
improper. Each party hereby irrevocably waives personal service of process and
consents to process being served in any such suit, action or proceeding by
mailing a copy thereof to such party at the address for such notices to it under
this Subscription Agreement and agrees that such service shall constitute good
and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any manner
permitted by law. Each party hereby irrevocably waives any right it may have,
and agrees not to request, a jury trial for the adjudication of any dispute
hereunder or in connection with or arising out of this Subscription Agreement or
any transaction contemplated hereby.

            4.5 Headings. The headings of this Subscription Agreement are for
convenience of reference and shall not form part of, or affect the
interpretation of, this Subscription Agreement.

            4.6 Successors And Assigns. This Subscription Agreement shall be
binding upon and inure to the benefit of the parties and their respective
successors and assigns. The Company shall not assign this Subscription Agreement
or any rights or obligations hereunder without the prior written consent of the
holders of at least a majority the Securities then outstanding, except by merger
or consolidation. The Subscriber shall not assign its rights hereunder without
the consent of the Company, which consent shall not be unreasonably withheld.

            4.7 No Third Party Beneficiaries. This Subscription Agreement is
intended for the benefit of the parties hereto and their respective permitted
successors and assigns, and is not for the benefit of, nor may any provision
hereof be enforced by, any other person.

            4.8 Survival. The representations and warranties of the Company and
the Subscriber contained in Articles I and II and the agreements set forth this
Article IV shall survive closing for a period of two years.

            4.9 Further Assurances. Each party shall do and perform, or cause to
be done and performed, all such further acts and things, and shall execute and
deliver all such other agreements, certificates, instruments and documents, as
the other party may reasonably request in order to carry out the intent and
accomplish the purposes of this Subscription Agreement and the consummation of
the transactions contemplated hereby.

            4.10 No Strict Construction. The language used in this Subscription
Agreement will be deemed to be the language chosen by the parties to express
their mutual intent, and no rules of strict construction will be applied against
any party.

            4.11 Legal Representation. The Subscriber acknowledges that: (a) it
has read this Subscription Agreement and the exhibits hereto; (b) it understands
that the Company has been represented in the preparation, negotiation, and
execution of this Subscription Agreement by Sichenzia Ross Friedman Ference LLP,

                                       10
<PAGE>

counsel to the Company; and (c) it understands the terms and consequences of
this Subscription Agreement and is fully aware of its legal and binding effect.

            4.12 Counterparts. This Subscription Agreement may be executed in
two or more identical counterparts, all of which shall be considered one and the
same agreement and shall become effective when counterparts have been signed by
each party and delivered to the other party; provided that a facsimile signature
shall be considered due execution and shall be binding upon the signatory
thereto with the same force and effect as if the signature were an original, not
a facsimile signature.

                            [Signature page follows.]

                                       11
<PAGE>

      IN WITNESS WHEREOF, the parties have executed this Subscription Agreement
as of the day and year first written above.

______________________________________         No. of Shares:   20,000__________
Name of Subscriber                             No. of Warrants: 20,000__________

_/s/ James Colen______________________
Signature

 James Colen___________________________
Name (Please Print)

--------------------------------------
Title

--------------------------------------

--------------------------------------

--------------------------------------
Address of Subscriber

--------------------------------------
Taxpayer Identification Number of Subscriber

                                               Subscription Accepted:

                                               PATIENT SAFETY TECHNOLOGIES, INC.

                                               By: /s/ Milton Ault
                                                   ---------------
                                               Name:  Milton "Todd" Ault
                                               Title: Chief Executive Officer

                                       12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00083-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00083-of-00352.parquet"}]]